Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Shanghai Pharmaceuticals: Dihydroxypropyltheophylline Injection Approved for Production
Shanghai Pharmaceuticals Co., Ltd. (Shanghai Yaoh) announcement: Recently, its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd., received a “Drug Registration Certificate” issued by the National Medical Products Administration (certificate number: 2026S00781) for its dihydrotheophylline injection, approving the drug for production. The drug is indicated for relief of wheezing symptoms in conditions such as bronchial asthma, wheezing-type bronchitis, and obstructive pulmonary emphysema. It can also be used for wheezing caused by cardiogenic pulmonary edema.